Merck Named One of Fortune’s 2023 100 Best Companies to Work For(R)

Go back to Merck Named One of Fortune’s 2023 100 Best Companies to Work For(R)

Merck (MRK) shares gain, Citi upgrades to buy as estimates ahead of consensus

April 13, 2023 10:31 AM EDT

Merck (NYSE: MRK) was lifted to Buy from Neutral, with its price target raised to $130 from $105 by Citi analyst Andrew Baum on Thursday.

The analyst said the firm's new estimates are 2-25% ahead of consensus, while their NPV "assumes a very conservative Keytruda... More